Qiagen (QGEN) Tops Q4 EPS by 1c; offers guidance

Qiagen (NYSE: QGEN) reported Q4 EPS of $0.61, $0.01 better than the analyst estimate of $0.60. Revenue for the quarter came in at $521 million versus the consensus estimate of $520.85 million.

GUIDANCE:

Qiagen sees FY2025 EPS of at least $2.28 CER, versus the consensus of $2.35.

For earnings history and earnings-related data on Qiagen (QGEN) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders